Our companion diagnostic (CDx) development partnering capabilities supports biopharma partners with CDx solutions to help overcome the challenges associated with identifying the right patient for the right drug in clinical development and after approval for commercialization.
We provide end-to-end CDx partnering solutions for our biopharma customers from initial biomarker discovery to commercialization.